PlainRecalls

Natures Pharmacy & Compounding Center

48 recalls on record · Latest: Mar 12, 2014

Natures Pharmacy & Compounding Center Recall Insight

Natures Pharmacy & Compounding Center appears on 48 federal recall records indexed by PlainRecalls, out of 83,949 total recalls tracked across the FDA, CPSC, NHTSA, and USDA FSIS. That represents approximately 0.057% of the federal archive — a data point that is only interpretable alongside production volume, product mix, and decades of operation, because a high recall count alone does not establish fault. Large, diversified firms that sell tens of millions of units across many categories will mechanically accumulate more recall records than small manufacturers, even when their defect rates per unit shipped are comparable or lower. The most recent action on this firm is dated Mar 12, 2014, which is the anchor point for assessing whether enforcement is currently active or historical.

On this page of 48 entries, severity tagging shows 0 critical, 48 moderate, and 0 lower-severity recalls. Affected-unit counts are disclosed on 1 of 48 entries — unit-count disclosure is more common on CPSC and NHTSA actions and less common on FDA drug/device recalls, where lot numbers and distribution scope substitute for absolute totals. The records on this page span 3 distinct product categories, with issuing agencies dominated by FDA Drug (48). The date window on this page runs from Mar 12, 2014 to Mar 12, 2014.

Manufacturer-level browsing is useful when monitoring a single firm for patterns — whether recalls cluster around one product family (suggesting a specific design or supplier issue) or scatter across the firm's entire catalog (which can indicate systemic quality-control problems or deliberate regulator attention). Clicking into each recall reveals the specific hazard, remedy, and distribution scope that together determine whether a consumer is actually at risk. For decisions that depend on being current — deciding whether a product in your home is safe, whether to return a gift, or whether to accept a replacement — always verify the recall number on the issuing agency's site, because federal agencies amend, terminate, and re-scope recalls over time and only the agency's live record reflects the current legal status. This page aggregates what agencies have published publicly and is intended for consumer awareness and research.

FDA Drug Moderate Mar 12, 2014

Papaverine 1nj 30mg/ml

FDA Drug Moderate Mar 12, 2014

5-Fluorouracil pf in methocel 1% opthal

FDA Drug Moderate Mar 12, 2014

Scopolamine 0.25 opth.

FDA Drug Moderate Mar 12, 2014

Pyridoxine (p-f) 100mg/ml

FDA Drug Moderate Mar 12, 2014

Methylcobalamin

FDA Drug Moderate Mar 12, 2014

Papaverine 12mg/phent 1mg/Pros 9mcq/ml

FDA Drug Moderate Mar 12, 2014

Ethanol 20% ophthal.

FDA Drug Moderate Mar 12, 2014

Dexamethasone (pf) 0.05 % opth.

FDA Drug Moderate Mar 12, 2014

Dexamethosone/Tobramycin pf 0.1%/0.3% ophthalmic

FDA Drug Moderate Mar 12, 2014

Novarel (IM)

FDA Drug Moderate Mar 12, 2014

EDTA 3% ophthalmic

FDA Drug Moderate Mar 12, 2014

Bleomycin Sulfate 1unit/ml

FDA Drug Moderate Mar 12, 2014

Voriconazole 0.5mg/ml

FDA Drug Moderate Mar 12, 2014

Methotrexate Intraocular 400mcg 0.1cc

FDA Drug Moderate Mar 12, 2014

Tacrolimus 0.02% opth. (H20-based)

FDA Drug Moderate Mar 12, 2014

Vit A (olive oil) 0.1% opth.

FDA Drug Moderate Mar 12, 2014

Folic acid (pf) 10mg/cc inj

FDA Drug Moderate Mar 12, 2014

Triamcinolone Acetonide 3mg/ml

FDA Drug Moderate Mar 12, 2014

Tacrolimus (H20-based) 0.03% ophth.

FDA Drug Moderate Mar 12, 2014

Voriconazole 1% opthal

FDA Drug Moderate Mar 12, 2014

Cyanocobalamin 100mcg/ml injection

FDA Drug Moderate Mar 12, 2014

Cyano B-12 p-f 1000mcg/ml

FDA Drug Moderate Mar 12, 2014

Sodium Bicarbonate 8.4% inj.

FDA Drug Moderate Mar 12, 2014

Cyano B-12 (Cmpd) 1000mcg/ml

FDA Drug Moderate Mar 12, 2014

Hydroxyprogesterone Caproate

FDA Drug Moderate Mar 12, 2014

Tetracaine 0.5% ophth.

FDA Drug Moderate Mar 12, 2014

Voriconazole 0.5mg/ml

FDA Drug Moderate Mar 12, 2014

Lidocaine 4% Urethral Gel

FDA Drug Moderate Mar 12, 2014

Dexamethasone phosphate 24mg/ml inj.

FDA Drug Moderate Mar 12, 2014

Glutathione Inhalation 200mg/5ml

FDA Drug Moderate Mar 12, 2014

Testosterone Cypionate 200mg/ml

FDA Drug Moderate Mar 12, 2014

Estradiol Cypionate 2mg/cc testosterone cypionoate 50mg

FDA Drug Moderate Mar 12, 2014

Prostaglandin all combinations

FDA Drug Moderate Mar 12, 2014

Bladder Instillation

FDA Drug Moderate Mar 12, 2014

Testosterone Cypionate 100mg/ml

FDA Drug Moderate Mar 12, 2014

Hydroxocobalamin inj.

FDA Drug Moderate Mar 12, 2014

5-Fluorouracil 1% ophthal

FDA Drug Moderate Mar 12, 2014

Vancomycin (fortified) 25mg/ml opth

FDA Drug Moderate Mar 12, 2014

AMP/M-B12/Pyridox/Methionine Inositol

FDA Drug Moderate Mar 12, 2014

Vitamin D (Ergocalciferol) 800 u/ml

FDA Drug Moderate Mar 12, 2014

Glutathione 6%/ascorbic 1%/DMSO 6.25%

FDA Drug Moderate Mar 12, 2014

Renacidin Irrigation

FDA Drug Moderate Mar 12, 2014

L-Glutathione inhalation

FDA Drug Moderate Mar 12, 2014

Glutathione 1.25%/Ascorbic 1.25%/DMSO 6.25%

FDA Drug Moderate Mar 12, 2014

Acetylcysteine 10% ophthalmic

FDA Drug Moderate Mar 12, 2014

Terbutaline/Ipratropium 0.5mg/2.5ml

FDA Drug Moderate Mar 12, 2014

Gentamycin 80mg/1000cc 0.9% NS

FDA Drug Moderate Mar 12, 2014

Idoxuridine 0.1% Ophthalmic

Nearby Manufacturers

Other firms with recall activity tracked in the PlainRecalls index.

Compare Natures Pharmacy & Compounding Center with FORD →

Data Sources

  • Source: FDA + CPSC + NHTSA + USDA FSIS — federal recall filings naming this firm. Verify with FDA, CPSC, NHTSA, or USDA FSIS directly.
  • Source: PlainRecalls Manufacturer Index — firm-level aggregation across all four federal recall feeds